Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Brazel

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 18, 2022
Non-small Cell Lung Cancer with EGFR or HER2 Exon 20 Insertion Mutations: Diagnosis and Treatment OptionsDanielle Brazel, Gianna Kroening, Misako Nagasaka
Lung Cancer (Auckland, N.Z.)|May 20, 2022
Spotlight on Tepotinib and Capmatinib for Non-Small Cell Lung Cancer with MET Exon 14 Skipping MutationDanielle Brazel, Shannon Zhang, Misako Nagasaka
Cureus|October 25, 2021
Warm and Cold Autoimmune Hemolytic Anemia in the Setting of COVID-19 DiseaseDanielle Brazel, Tarek Eid, Cameron Harding
Journal of the Neurological Sciences|September 23, 2022
Stroke in sickle cell disease and the promise of recent disease modifying agentsAva Runge, Danielle Brazel, Zahra Pakbaz
Cureus|November 10, 2025
A Case of Immunotherapy-Induced BalanitisTerrence Sun, Danielle Brazel, Aditya Sarvaria
Journal of Community Hospital Internal Medicine Perspectives|September 27, 2021
A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it's 2021, are we there yet?Ava Runge, Danielle Brazel, Zahra Pakbaz
Lung Cancer (Auckland, N.Z.)|November 17, 2022
A Long Overdue Targeted Treatment for KRAS Mutations in NSCLC: Spotlight on AdagrasibDanielle Brazel, Zhaohui Arter, Misako Nagasaka
Journal of Medical Cases|November 29, 2024
A Case of Autoimmune Neutropenia That Responded to RituximabJustin Dejia Wang, Danielle Brazel, Emily Nagler
Leukemia & Lymphoma|September 1, 2025
Threading through the data for chemotherapy-free alternatives in the treatment of hairy cell leukemiaDanielle Brazel, David J Hermel, Alan Saven
Critical Reviews in Oncology/Hematology|August 15, 2025
The development of Zongertinib for HER2-mutant NSCLCDanielle Brazel, Cathleen J Park, Misako Nagasaka
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 18, 2022
Non-small Cell Lung Cancer with EGFR or HER2 Exon 20 Insertion Mutations: Diagnosis and Treatment OptionsDanielle Brazel, Gianna Kroening, Misako Nagasaka
Lung Cancer (Auckland, N.Z.)|May 20, 2022
Spotlight on Tepotinib and Capmatinib for Non-Small Cell Lung Cancer with MET Exon 14 Skipping MutationDanielle Brazel, Shannon Zhang, Misako Nagasaka
Cureus|October 25, 2021
Warm and Cold Autoimmune Hemolytic Anemia in the Setting of COVID-19 DiseaseDanielle Brazel, Tarek Eid, Cameron Harding
Journal of the Neurological Sciences|September 23, 2022
Stroke in sickle cell disease and the promise of recent disease modifying agentsAva Runge, Danielle Brazel, Zahra Pakbaz
Cureus|November 10, 2025
A Case of Immunotherapy-Induced BalanitisTerrence Sun, Danielle Brazel, Aditya Sarvaria
Journal of Community Hospital Internal Medicine Perspectives|September 27, 2021
A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it's 2021, are we there yet?Ava Runge, Danielle Brazel, Zahra Pakbaz
Lung Cancer (Auckland, N.Z.)|November 17, 2022
A Long Overdue Targeted Treatment for KRAS Mutations in NSCLC: Spotlight on AdagrasibDanielle Brazel, Zhaohui Arter, Misako Nagasaka
Journal of Medical Cases|November 29, 2024
A Case of Autoimmune Neutropenia That Responded to RituximabJustin Dejia Wang, Danielle Brazel, Emily Nagler
Leukemia & Lymphoma|September 1, 2025
Threading through the data for chemotherapy-free alternatives in the treatment of hairy cell leukemiaDanielle Brazel, David J Hermel, Alan Saven
Critical Reviews in Oncology/Hematology|August 15, 2025
The development of Zongertinib for HER2-mutant NSCLCDanielle Brazel, Cathleen J Park, Misako Nagasaka
Pageof 5